| 1 | Демихов В. П. Пересадка жизненно важных органов в эксперименте. – 1960. – Москва: Медгиз, 1960. – 259 с. |
| 2 | Hardy J. D. et al. Lung homotransplantation in man: report of the initial case //Jama. – 1963. – Т. 186. – №. 12. – С. 1065-1074. |
| 3 | Cooley D.A. et al. Organ Transplantetion for advanced cardiopulmonary disease. Ann Thorac Surg 1964;8:30-46. |
| 4 | Nelems J. et al. Human lung transplantation. Chest. – 1980. – Vol. 186. – № 12. – P. 569- 573. |
| 5 | Яблонский, П. К. Трансплантация изолированного легкого (Экспериментальное и клиническое исследование): специальность 14.00.27 «Хирургия»:автореферат диссертации на соискание ученой степени доктора медицинских наук / Яблонский Петр Казимирович ; Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова. – Санкт- Петербург, 1999. – 32 с. - Библиогр.: с. 32-34. - Текст: непосредственный. |
| 6 | Первая в России успешная двусторонняя трансплантация легких / П.К. Яблонский, А.Г Чучалин, Ж. Массард и др. - Текст: непосредственный // Вестник хирургии. - 2007. — Т. 166. — № 1. — С. 88–95. – Библиогр.: с. 95 (назв.7). |
| 7 | Первая трансплантация легких в НИИ скорой помощи им. Н.В. Склифосовского / М.Ш. Хубутия, А. Г. Чучалин, М.М. Абакумов и др.-Текст: непосредственный // Трансплантология. - 2011. — № 2-3. — С. 5–9. – Библиогр.: с. 9 (назв. 7). |
| 8 | Готье С. В. Трансплантология: итоги и перспективы. Том VI. 2014 год / С.В. Готье. - Текст: непосредственный // Тверь: Триада. – 2015. – С. 448. |
| 9 | Yusen R. D. et al. The registry of the international society for heart and lung transplantation: thirty-third adult lung and heart–lung transplant report—2016; focus theme: primary diagnostic indications for transplant //The Journal of Heart and Lung Transplantation. – 2016. – Т. 35. – №. 10. – С. 1170-1184. |
| 10 | Weill D. et al. A consensus document for the selection of lung transplant candidates: 2014—an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. – 2015. |
| 11 | Chambers D. C. et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart–lung transplantation Report—2019; Focus theme: Donor and recipient size match |
| | //The Journal of Heart and Lung Transplantation. – 2019. – Т. 38. – №. 10. – С. 1042- 1055. |
| 12 | Сведения о смертности населения по причинам смерти по Российской Федерации за январь - декабрь 2018 года / Федеральная служба государственной статистики - Текст: электронный // Официальная статистика. - 2019. - URL: http://webcache.googleusercontent.com/search?q=cache:YcYhzF1iCykJ:www.gks.ru/fr ee_doc/2018/demo/t3_3.xls+&cd=1&hl=ru&ct=clnk&gl=ru |
| 13 | Готье С.В. Оценка потребности населения в трансплантации органов, донорского ресурса и планирование эффективной сети медицинских организаций (центров трансплантации) / С.В. Готье, С.М. Хомяков. - Текст: непосредственный // Вестник трансплантологии и искусственных органов. - 2018. - Т. 15. - № 3. С. 11- 24. - Библиогр.: с. 24 (назв.4) |
| 14 | О порядке установления диагноза смерти мозга человека: Приказ Министерства здравоохранения РФ от 25 декабря 2014 г. № 908н : сайт / Справочная правовая система «ГАРАНТ.РУ». - 2014. - URL: http:// http://www.garant.ru/products/ipo/prime/doc/70921232 (дата обращения: ) - Текст: электронный. |
| 15 | Martens A. et al. A retrospective database analysis to evaluate the potential of ex vivo lung perfusion to recruit declined lung donors //Transplant International. – 2017. – Т. 30. – №. 10. – С. 1002-1010. |
| 16 | Thabut G. et al. Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data //The Lancet. – 2008. – Т. 371. – №. 9614. – С. 744-751. |
| 17 | Crawford T. C. et al. Five-year mortality hazard is reduced in chronic obstructive pulmonary disease patients receiving double-versus single-lung transplants //Journal of Surgical Research. – 2019. – Т. 237. – С. 118-125. |
| 18 | Antończyk R. et al. Single Lung Transplant vs Double Lung Transplant: A Single-Center Experience With Particular Consideration for Idiopathic Pulmonary Arterial Hypertension //Transplantation Proceedings. – Elsevier, 2020. |
| 19 | Pierson III R. N. et al. Successful management of an ABO-mismatched lung allograft using antigen-specific immunoadsorption, complement inhibition, and immunomodulatory therapy1 //Transplantation. – 2002. – Т. 74. – №. 1. – С. 79-84. |
| 20 | Snell G. I. et al. Lessons and insights from ABO‐incompatible lung transplantation //American Journal of Transplantation. – 2013. – Т. 13. – №. 5. – С. 1350-1353. |
| 21 | Novick R. J. et al. Pulmonary Retransplantation: Predictors of Graft Function and Survival |
| | in 230 Patients-reporting on studies using secondary data sources //The Annals of Thoracic Surgery. – 1998. – Т. 65. – №. 1. – С. 227-234. |
| 22 | Aigner C. et al. Pulmonary retransplantation: is it worth the effort? A long-term analysis of 46 cases //The Journal of heart and lung transplantation. – 2008. – Т. 27. – №. 1. – С. 60- 65. |
| 23 | Santambrogio L. et al. Transplant options for end stage chronic obstructive pulmonary disease in the context of multidisciplinary treatments //Journal of Thoracic Disease. – 2018. – Т. 10. – №. Suppl 27. – С. S3356. |
| 24 | Lane C. R., Tonelli A. R. Lung transplantation in chronic obstructive pulmonary disease: patient selection and special considerations //International journal of chronic obstructive pulmonary disease. – 2015. – Т. 10. – С. 2137. |
| 25 | Aziz F. et al. Lung transplant in end-staged chronic obstructive pulmonary disease (COPD) patients: a concise review //Journal of thoracic disease. – 2010. – Т. 2. – №. 2. – С. 111. |
| 26 | Siddiqui F. M., Diamond J. M. Lung transplantation for chronic obstructive pulmonary disease: past, present, and future directions //Current opinion in pulmonary medicine. – 2018. – Т. 24. – №. 2. – С. 199. |
| 27 | Pirard L., Marchand E. Reassessing the BODE score as a criterion for listing COPD patients for lung transplantation //International journal of chronic obstructive pulmonary disease. – 2018. – Т. 13. – С. 3963. |
| 28 | Zeng G. S. et al. The relationship between steps of 6MWT and COPD severity: a cross- sectional study //International journal of chronic obstructive pulmonary disease. – 2019. – Т. 14. – С. 141. |
| 29 | Pooja P., Vinita A. Significance of six minute walk test (6MWT) in COPD patients //Work. – 2017. – Т. 32. – С. 0.0001. |
| 30 | Waatevik M. et al. Oxygen desaturation in 6-min walk test is a risk factor for adverse outcomes in COPD //European Respiratory Journal. – 2016. – Т. 48. – №. 1. – С. 82-91. |
| 31 | Reed R. M. et al. Survival of lung transplant candidates with COPD: BODE score reconsidered //Chest. – 2018. – Т. 153. – №. 3. – С. 697-701. |
| 32 | Eskander A. et al. BODE index and quality of life in advanced chronic obstructive pulmonary disease before and after lung transplantation //The Journal of heart and lung transplantation. – 2011. – Т. 30. – №. 12. – С. 1334-1341. |
| 33 | Timofte I. et al. Survival benefit of lung transplantation compared with medical management and pulmonary rehabilitation for patients with end-stage COPD //ERJ Open Research. – 2020. – Т. 6. – №. 2. |
| 34 | Marchetti N., Criner G. J. Surgical approaches to treating emphysema: lung volume reduction surgery, bullectomy, and lung transplantation //Seminars in respiratory and critical care medicine. – Thieme Medical Publishers, 2015. – Т. 36. – №. 04. – С. 592-608. |
| 36 | Buttery S. et al. CELEB trial: Comparative Effectiveness of Lung volume reduction surgery for Emphysema and Bronchoscopic lung volume reduction with valve placement: a protocol for a randomised controlled trial //BMJ open. – 2018. – Т. 8. – №. 10. – С. e021368. |
| 37 | Tutic M. et al. Lung-volume reduction surgery as an alternative or bridging procedure to lung transplantation //The Annals of thoracic surgery. – 2006. – Т. 82. – №. 1. – С. 208- 213. |
| 38 | De Oliveira N. C. et al. Lung transplant for interstitial lung disease: outcomes for single versus bilateral lung transplantation //Interactive cardiovascular and thoracic surgery. – 2012. – Т. 14. – №. 3. – С. 263-267. |
| 39 | Park J. E. et al. Comparison of short-term outcomes for connective tissue disease-related interstitial lung disease and idiopathic pulmonary fibrosis after lung transplantation //Journal of Thoracic Disease. – 2018. – Т. 10. – №. 3. – С. 1538. |
| 40 | Kubo M. et al. Lung transplantation in patients with scleroderma //The Journal of Heart and Lung Transplantation. – 2001. – Т. 20. – №. 2. – С. 174-175. |
| 41 | Saggar R. et al. Systemic sclerosis and bilateral lung transplantation: a single centre experience //European Respiratory Journal. – 2010. – Т. 36. – №. 4. – С. 893-900. |
| 42 | Schachna L. et al. Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension //Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. – 2006. – Т. 54. – №. 12. – С. 3954-3961. |
| 43 | Shitrit D. et al. Lung transplantation in patients with scleroderma: case series, review of the literature, and criteria for transplantation //Clinical transplantation. – 2009. – Т. 23. – №. 2. – С. 178-183. |
| 44 | Raghu G. et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management //American journal of respiratory and critical care medicine. – 2011. – Т. 183. – №. 6. – С. 788-824. |
| 45 | Laporta Hernandez R. et al. Lung transplantation in idiopathic pulmonary fibrosis //Medical Sciences. – 2018. – Т. 6. – №. 3. – С. 68. |
| 46 | Fisher J. H. et al. Multi-dimensional scores to predict mortality in patients with idiopathic pulmonary fibrosis undergoing lung transplantation assessment //Respiratory Medicine. – 2017. – Т. 125. – С. 65-71. |
| 47 | Авдеев С. Н., Чикина С. Ю., Нагаткина О. В. Идиопатический легочный фиброз: новые международные клинические рекомендации //Пульмонология. – 2019. – Т. 29. – №. 5. – С. 525-552. |
| 48 | Fernández Fabrellas E. et al. Prognosis and follow-up of idiopathic pulmonary fibrosis //Medical Sciences. – 2018. – Т. 6. – №. 2. – С. 51. |
| 49 | Lancaster L. H. Utility of the six-minute walk test in patients with idiopathic pulmonary fibrosis //Multidisciplinary respiratory medicine. – 2018. – Т. 13. – №. 1. – С. 1-7. |
| 50 | Snyder L. et al. Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO registry //Respiratory research. – 2019. – Т. 20. – №. 1. – С. 105. |
| 51 | Kumar A. et al. Lung transplantation in idiopathic pulmonary fibrosis //Expert review of respiratory medicine. – 2018. – Т. 12. – №. 5. – С. 375-385. |
| 52 | Thabut G. et al. Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis //The Journal of thoracic and cardiovascular surgery. – 2003. – Т. 126. – №. 2. – С. 469-475. |
| 53 | Kistler K. D. et al. Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature //BMC pulmonary medicine. – 2014. – Т. 14. – №. 1. – С. 139. |
| 54 | Savi D. et al. Survival after lung transplant for cystic fibrosis in Italy: a single center experience with 20 years of follow-up //Transplantation Proceedings. – Elsevier, 2018. – Т. 50. – №. 10. – С. 3732-3738. |
| 55 | Lynch III J. P. et al. Lung transplantation for cystic fibrosis: results, indications, complications, and controversies //Seminars in respiratory and critical care medicine. – NIH Public Access, 2015. – Т. 36. – №. 2. – С. 299. |
| 56 | Snell G. et al. The evolution of lung transplantation for cystic fibrosis: a 2017 update //Journal of Cystic Fibrosis. – 2017. – Т. 16. – №. 5. – С. 553-564. |
| 57 | Rosenbluth D. B. et al. Lung function decline in cystic fibrosis patients and timing for lung transplantation referral //Chest. – 2004. – Т. 126. – №. 2. – С. 412-419. |
| 58 | Mayer-Hamblett N. et al. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality //American journal of respiratory and critical care medicine. – 2002. – Т. 166. – №. 12. – С. 1550-1555. |
| 59 | Augarten A. et al. Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients //Pediatric transplantation. – 2001. – Т. 5. – №. 5. – С. 339-342. |
| 60 | Milla C. E., Warwick W. J. Risk of death in cystic fibrosis patients with severely compromised lung function //Chest. – 1998. – Т. 113. – №. 5. – С. 1230-1234. |
| 61 | Liou T. G. et al. Survival effect of lung transplantation among patients with cystic fibrosis |
| | //Jama. – 2001. – Т. 286. – №. 21. – С. 2683-2689. |
| 62 | Tuppin M. P. et al. Predictive utility of the 6-minute walk distance on survival in patients awaiting lung transplantation //The Journal of heart and lung transplantation. – 2008. – Т. 27. – №. 7. – С. 729-734. |
| 63 | Chaparro, Cecilia, et al. "Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation." American journal of respiratory and critical care medicine 163.1 (2001): 43-48. |
| 64 | Chernenko, Susan M., et al. "Mycobacterium abscessus infections in lung transplant recipients: the international experience." The Journal of heart and lung transplantation 25.12 (2006): 1447-1455 |
| 65 | Raats D. et al. Successful lung transplantation for chronic Mycobacterium abscessus infection in advanced cystic fibrosis, a case series //Transplant Infectious Disease. – 2019. – Т. 21. – №. 2. – С. e13046. |
| 66 | Lobo, Leonard J., et al. "Lung transplant outcomes in cystic fibrosis patients with pre‐operative M ycobacterium abscessus respiratory infections." Clinical transplantation 27.4 (2013): 523-529. |
| 67 | Olivier, Kenneth N., et al. "Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease // American journal of respiratory and critical care medicine 195.6 (2017): 814-823. |
| 68 | Osmani M. et al. Mycobacterium abscessus infections in lung transplant recipients: 15‐year experience from a single institution //Transplant Infectious Disease. – 2018. – Т. 20. – №. 2. – С. e12835. |
| 69 | Knoll B. M. et al. Non‐tuberculous mycobacterial infection among lung transplant recipients: a 15‐year cohort study //Transplant Infectious Disease. – 2012. – Т. 14. – №. 5. – С. 452-460. |
| 70 | Longworth S. A. et al. Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: a case–control study //Transplant Infectious Disease. – 2014. – Т. 16. – №. 1. – С. 76-83. |
| 71 | Vandamme, Peter, et al. "Occurrence of Multiple Genomovars of Burkholderia cepacia in Cystic Fibrosis Patients and Proposal of Burkholderia multivorans sp. nov." International Journal of Systematic and Evolutionary Microbiology 47.4 (1997): 1188-1200. |
| 72 | Mariencheck Jr, W. I., et al. "Survival following lung transplantation of cystic fibrosis patients colonized with Burkholderia cepacia // Am J Respir Crit Care Med 161 (2000): 720. |
| 73 | De Soyza, Anthony, et al. "Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis." The Lancet 358.9295 (2001): 1780-1781. |
| 74 | ARIS, ROBERT M., et al. "Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex: survival linked to genomovar type // American journal of respiratory and critical care medicine 164.11 (2001): 2102-2106. |
| 75 | Coenye, Tom, et al. "Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients." International Journal of Systematic and Evolutionary Microbiology 51.2 (2001): 271-279. |
| 76 | Meachery, G. J., et al. "185: Survival outcomes following lung transplantation for cystic fibrosis patients infected with Burkholderia cenocepacia–a UK experience." The Journal of Heart and Lung Transplantation 26.2 (2007): S126-S127. |
| 77 | Murray S. et al. Impact of Burkholderia infection on lung transplantation in cystic fibrosis //American journal of respiratory and critical care medicine. – 2008. – Т. 178. – №. 4. – С. 363-371. |
| 78 | Carraro, D. S., et al. "Study of Burkholderia Cepacia Complex Strains in Lung Transplant Patients: Analysis of Genomovar and Mortality Impact." The Journal of Heart and Lung Transplantation 33.4 (2014): S182. |
| 79 | Lay, Cecilia, et al. "Outcomes in cystic fibrosis lung transplant recipients infected with organisms labeled as pan-resistant: An ISHLT Registry‒based analysis." The Journal of Heart and Lung Transplantation 38.5 (2019): 545-552. |
| 80 | Boussaud V. et al. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres //Thorax. – 2008. – Т. 63. – №. 8. – С. 732-737. |
| 81 | Blatter, Joshua, and Stuart Sweet. "Lung transplantation in cystic fibrosis: trends and controversies //Pediatric allergy, immunology, and pulmonology 28.4 (2015): 237-243. |
| 82 | Galiè N. et al. Рекомендации ESC/ERS по диагностике и лечению легочной гипертензии 2015 //Российский кардиологический журнал. – 2016. – №. 5. – С. 5-64. |
| 83 | Mendeloff E. N. et al. Lung transplantation for pulmonary vascular disease //The Annals of thoracic surgery. – 2002. – Т. 73. – №. 1. – С. 209-219. |
| 84 | George M. P., Champion H. C., Pilewski J. M. Lung transplantation for pulmonary hypertension //Pulmonary circulation. – 2011. – Т. 1. – №. 2. – С. 182-191. |
| 85 | Quezada-Loaiza C. A. et al. Lung transplantation in pulmonary hypertension: a multidisciplinary unit's management experience //Transplantation Proceedings. – Elsevier, 2018. – Т. 50. – №. 5. – С. 1496-1503. |
| 86 | Hill C. et al. Heart–lung vs. double‐lung transplantation for idiopathic pulmonary arterial hypertension //Clinical Transplantation. – 2015. – Т. 29. – №. 12. – С. 1067-1075. |
| 87 | Ochman M. et al. Lung transplantation as a viable option of treatment for pulmonary veno- occlusive disease //Advances in respiratory medicine. – 2018. – Т. 86. – №. 5. – С. 249- 254. |
| 88 | López-Meseguer M. et al. Lung and heart-lung transplantation in pulmonary arterial hypertension //PloS one. – 2017. – Т. 12. – №. 11. – С. e0187811. |
| 89 | Le Pavec J., Hascoët S., Fadel E. Heart-lung transplantation: current indications, prognosis and specific considerations //Journal of Thoracic Disease. – 2018. – Т. 10. – №. 10. – С. 5946. |
| 90 | Choong C. K. et al. Repair of congenital heart lesions combined with lung transplantation for the treatment of severe pulmonary hypertension: a 13-year experience //The Journal of Thoracic and Cardiovascular Surgery. – 2005. – Т. 129. – №. 3. – С. 661-669. |
| 91 | Januszewska K. et al. Heart–lung transplantation in patients with pulmonary atresia and ventricular septal defect //The Journal of thoracic and cardiovascular surgery. – 2009. – Т. 138. – №. 3. – С. 738-743. |
| 92 | Huddleston C. B., Richey S. R. Heart-lung transplantation //Journal of thoracic disease. – 2014. – Т. 6. – №. 8. – С. 1150. |
| 93 | Hjortshøj C. S. et al. Outcome after heart–lung or lung transplantation in patients with Eisenmenger syndrome //Heart. – 2020. – Т. 106. – №. 2. – С. 127-132. |
| 94 | Toyoda Y., Toyoda Y. Heart-lung transplantation: adult indications and outcomes //Journal of thoracic disease. – 2014. – Т. 6. – №. 8. – С. 1138. |
| 95 | Khush K. K. et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-fifth adult heart transplantation report—2018; focus theme: multiorgan transplantation //The Journal of Heart and Lung Transplantation. – 2018. – Т. 37. – №. 10. – С. 1155-1168. |
| 96 | Fadel E. et al. Long-term outcome of double-lung and heart–lung transplantation for pulmonary hypertension: a comparative retrospective study of 219 patients //European journal of cardio-thoracic surgery. – 2010. – Т. 38. – №. 3. – С. 277-284. |
| 97 | Sottile P. D. et al. Outcomes in systemic sclerosis-related lung disease following lung transplantation //Transplantation. – 2013. – Т. 95. – №. 7. – С. 975. |
| 98 | Bernstein E. J. et al. Survival of adults with systemic sclerosis following lung transplantation: a nationwide cohort study //Arthritis & rheumatology. – 2015. – Т. 67. – №. 5. – С. 1314-1322. |
| 99 | Strek M. E. Systemic sclerosis‐associated interstitial lung disease: Role of the oesophagus in outcomes //Respirology. – 2018. – Т. 23. – №. 10. – С. 885-886. |
| 100 | Eberlein M., Mathai S. C. Lung transplantation in scleroderma. Time for the pendulum to swing?. – 2016. |
| 101 | Chan E. Y. et al. Long-term survival in bilateral lung transplantation for scleroderma- related lung disease //The Annals of Thoracic Surgery. – 2018. – Т. 105. – №. 3. – С. 893- 900. |
| 102 | Crespo M. M. et al. Lung transplant in patients with scleroderma compared with pulmonary fibrosis. Short-and long-term outcomes //Annals of the American Thoracic Society. – 2016. – Т. 13. – №. 6. – С. 784-792. |
| 103 | Pradère P. et al. Lung transplantation for scleroderma lung disease: an international, multicenter, observational cohort study //The Journal of Heart and Lung Transplantation. – 2018. – Т. 37. – №. 7. – С. 903-911. |
| 104 | Чиссов В. И. Онкология: нац. рук. – ГЭОТАР-Медиа, 2008. |
| 105 | Zorn Jr G. L. et al. Pulmonary transplantation for advanced bronchioloalveolar carcinoma //The Journal of thoracic and cardiovascular surgery. – 2003. – Т. 125. – №. 1. – С. 45-48. |
| 106 | Kachala S. S., Murthy S. C. Lung transplantation for multifocal lung adenocarcinoma (multifocal lung carcinoma) //Thoracic Surgery Clinics. – 2014. – Т. 24. – №. 4. – С. 485- 491. |
| 107 | de Perrot M. et al. Role of lung transplantation in the treatment of bronchogenic carcinomas for patients with end-stage pulmonary disease //Journal of clinical oncology. – 2004. – Т. 22. – №. 21. – С. 4351-4356. |
| 108 | Brand T., Haithcock B. Lung cancer and lung transplantation //Thoracic Surgery in the Special Care Patient, An Issue of Thoracic Surgery Clinics, E-Book. – 2017. – Т. 28. – №. 1. – С. 15-18. |
| 109 | Glanville A. R., Wilson B. E. Lung transplantation for non-small cell lung cancer and multifocal bronchioalveolar cell carcinoma //The Lancet Oncology. – 2018. – Т. 19. – №. 7. – С. e351-e358. |
| 110 | Machuca T. N., Keshavjee S. Transplantation for lung cancer //Current opinion in organ transplantation. – 2012. – Т. 17. – №. 5. – С. 479-484. |
| 111 | Klikovits T. et al. Lung transplantation in patients with incidental early stage lung cancer—institutional experience of a high volume center //Clinical transplantation. – 2016. – Т. 30. – №. 8. – С. 912-917. |
| 112 | Ahmad U. et al. Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing Registry //The Annals of thoracic surgery. – 2012. – Т. 94. – №. 3. – С. |
| | 935-941. |
| 113 | Paloyan E. B. et al. Lung transplantation for advanced bronchioloalveolar carcinoma confined to the lungs //Transplantation. – 2000. – Т. 69. – №. 11. – С. 2446-2448. |
| 114 | Mathew J., Kratzke R. A. Lung cancer and lung transplantation: a review //Journal of Thoracic Oncology. – 2009. – Т. 4. – №. 6. – С. 753-760. |
| 115 | Benden C. Pediatric lung transplantation //Journal of thoracic disease. – 2017. – Т. 9. – №. 8. – С. 2675. |
| 116 | Spray T. L. et al. Pediatric lung transplantation: indications, techniques, and early results //The Journal of Thoracic and Cardiovascular Surgery. – 1994. – Т. 107. – №. 4. – С. 990- 1000. |
| 117 | Blatter J. A., Noyes B., Sweet S. C. Pediatric lung transplantation //Kendig's Disorders of the Respiratory Tract in Children. – Content Repository Only!, 2019. – С. 981-991. e4. |
| 118 | Schmid F. A., Benden C. Special considerations for the use of lung transplantation in pediatrics //Expert Review of Respiratory Medicine. – 2016. – Т. 10. – №. 6. – С. 655-662. |
| 119 | Khan M. S. et al. Is lung transplantation survival better in infants? Analysis of over 80 infants //The Journal of Heart and Lung Transplantation. – 2013. – Т. 32. – №. 1. – С. 44- 49. |
| 120 | Soares J. J. et al. Childhood interstitial lung diseases: an 18-year retrospective analysis //Pediatrics. – 2013. – Т. 132. – №. 4. – С. 684-691. |
| 121 | Benoit T. M., Benden C. Pediatric lung transplantation: supply and demand //Current opinion in organ transplantation. – 2019. – Т. 24. – №. 3. – С. 324-328. |
| 122 | Eldridge W. B. et al. Outcomes of lung transplantation for infants and children with genetic disorders of surfactant metabolism //The Journal of pediatrics. – 2017. – Т. 184. – С. 157-164. e2. |
| 123 | Dellon E. et al. Pediatric lung transplantation and end of life care in cystic fibrosis: Barriers and successful strategies //Pediatric Pulmonology. – 2017. – Т. 52. – №. S48. – С. S61-S68. |
| 124 | Riggs K. W. et al. Pediatric heart‐lung transplantation: A contemporary analysis of outcomes //Pediatric Transplantation. – 2020. – Т. 24. – №. 3. – С. e13682. |
| 125 | Novick R. J., Stitt L. Pulmonary retransplantation //Seminars in thoracic and cardiovascular surgery. – WB Saunders, 1998. – Т. 10. – №. 3. – С. 227-236. |
| 126 | Roy S. B. et al. Lung retransplantation for chronic rejection: a single-center experience //The Annals of Thoracic Surgery. – 2018. – Т. 105. – №. 1. – С. 221-227. |
| 127 | Doyle S. et al. Predictive Utility of Lung Allocation Score for Retransplantation Outcomes //The Annals of thoracic surgery. – 2018. – Т. 106. – №. 5. – С. 1525-1532. |
| 128 | Brugieère O. et al. Lung retransplantation for bronchiolitis obliterans syndrome: long-term follow-up in a series of 15 recipients //Chest. – 2003. – Т. 123. – №. 6. – С. 1832-1837. |
| 129 | Kawut S. M. et al. Outcomes after lung retransplantation in the modern era //American journal of respiratory and critical care medicine. – 2008. – Т. 177. – №. 1. – С. 114-120. |
| 130 | Kawut S. M. Lung retransplantation //Clinics in chest medicine. – 2011. – Т. 32. – №. 2. – С. 367-377. |
| 131 | Hall D. J. et al. Two decades of lung retransplantation: a single-center experience //The Annals of thoracic surgery. – 2017. – Т. 103. – №. 4. – С. 1076-1083. |
| 132 | Ren D. et al. Retransplantation outcomes at a large lung transplantation program //Transplantation Direct. – 2018. – Т. 4. – №. 11. |
| 133 | Lindstedt S. et al. Pulmonary retransplantation in the Nordic countries //The Annals of Thoracic Surgery. – 2015. – Т. 99. – №. 5. – С. 1781-1787. |
| 134 | Strueber M. et al. Long-term outcome after pulmonary retransplantation //The Journal of thoracic and cardiovascular surgery. – 2006. – Т. 132. – №. 2. – С. 407-412. |
| 135 | Aigner C. Retransplantation //Current opinion in organ transplantation. – 2015. – Т. 20. – №. 5. – С. 521-526. |
| 136 | Wigfield C. H., Buie V., Onsager D. “Age” in lung transplantation: factors related to outcomes and other considerations //Current pulmonology reports. – 2016. – Т. 5. – №. 3. – С. 152-158. |
| 137 | Courtwright A., Cantu E. Lung transplantation in elderly patients //Journal of thoracic disease. – 2017. – Т. 9. – №. 9. – С. 3346. |
| 138 | Hayanga A. J. et al. Contemporary analysis of early outcomes after lung transplantation in the elderly using a national registry //The Journal of Heart and Lung Transplantation. – 2015. – Т. 34. – №. 2. – С. 182-188. |
| 139 | Roy S. B. et al. Is there an age limit to lung transplantation? //The Annals of thoracic surgery. – 2015. – Т. 100. – №. 2. – С. 443-451. |
| 140 | Black S. M. et al. Influence of donor and recipient age in lung transplantation //J Heart Lung Transplant. – 2015. – Т. 34. – №. 1. – С. 43-49. |
| 141 | Madill J. et al. Nutritional assessment of the lung transplant patient: body mass index as a predictor of 90–day mortality following transplantation //The Journal of heart and lung transplantation. – 2001. – Т. 20. – №. 3. – С. 288-296. |
| 142 | Lederer D. J. et al. Obesity and underweight are associated with an increased risk of death after lung transplantation //American journal of respiratory and critical care medicine. – |
| | 2009. – Т. 180. – №. 9. – С. 887-895. |
| 143 | Kanasky Jr W. F. et al. Impact of body weight on long-term survival after lung transplantation //Chest. – 2002. – Т. 121. – №. 2. – С. 401-406. |
| 144 | Singer J. P. et al. Body composition and mortality after adult lung transplantation in the United States //American journal of respiratory and critical care medicine. – 2014. – Т. 190. – №. 9. – С. 1012-1021. |
| 145 | Upala S. et al. Underweight and obesity increase the risk of mortality after lung transplantation: a systematic review and meta‐analysis //Transplant International. – 2016. – Т. 29. – №. 3. – С. 285-296. |
| 146 | Bozso S. J. et al. Impact of obesity on heart and lung transplantation: does pre-transplant obesity affect outcomes? //Transplantation Proceedings. – Elsevier, 2017. – Т. 49. – №. 2. – С. 344-347. |
| 147 | Førli L. et al. The influence of underweight and dietary support on well-being in lung transplant candidates //Respiratory medicine. – 2006. – Т. 100. – №. 7. – С. 1239-1246. |
| 148 | Komatsu T. et al. Severe underweight decreases the survival rate in adult lung transplantation //Surgery today. – 2017. – Т. 47. – №. 10. – С. 1243-1248. |
| 149 | Ruttens D. et al. Body mass index in lung transplant candidates: a contra-indication to transplant or not? //Transplantation proceedings. – Elsevier, 2014. – Т. 46. – №. 5. – С. 1506-1510. |
| 150 | Ramos K. J. et al. Underweight patients with cystic fibrosis have acceptable survival following lung transplantation: a united network for organ sharing registry study //Chest. – 2020. |
| 151 | Aris R. M. et al. Severe osteoporosis before and after lung transplantation //Chest. – 1996. – Т. 109. – №. 5. – С. 1176-1183. |
| 152 | Shane E. et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease //The American journal of medicine. – 1996. – Т. 101. – №. 3. – С. 262-269. |
| 153 | Spira A. et al. Osteoporosis and lung transplantation: a prospective study //Chest. – 2000. – Т. 117. – №. 2. – С. 476-481. |
| 154 | Tschopp O. et al. Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease //American journal of transplantation. – 2002. – Т. 2. – №. 2. – С. 167-172. |
| 155 | Lakey W. C. et al. Osteoporosis in lung transplant candidates compared to matched healthy controls //Clinical transplantation. – 2011. – Т. 25. – №. 3. – С. 426-435. |
| 156 | Detterbeck F. C., Egan T. M., Mill M. R. Lung transplantation after previous thoracic surgical procedures //The Annals of thoracic surgery. – 1995. – Т. 60. – №. 1. – С. 139- 143. |
| 157 | Curtis H. J. et al. Lung transplantation outcome in cystic fibrosis patients with previous pneumothorax //The Journal of heart and lung transplantation. – 2005. – Т. 24. – №. 7. – С. 865-869. |
| 158 | Shigemura N. et al. Lung transplantation in patients with prior cardiothoracic surgical procedures //American Journal of Transplantation. – 2012. – Т. 12. – №. 5. – С. 1249- 1255. |
| 159 | Omara M. et al. Lung transplantation in patients who have undergone prior cardiothoracic procedures //The Journal of Heart and Lung Transplantation. – 2016. – Т. 35. – №. 12. – С. 1462-1470. |
| 160 | Thibodeau A. Mechanical pleurodesis is not a contraindication to lung transplantation //Clinical Research in Practice: The Journal of Team Hippocrates. – 2018. – Т. 4. – №. 1. – С. 5. |
| 161 | Leard L. E. Lung transplantation after prior cardiothoracic surgery: To transplant or not to transplant //The Journal of Heart and Lung Transplantation. – 2016. – Т. 35. – №. 11. – С. 1284-1285. |
| 162 | Hinske L. C. et al. Predicting the necessity for extracorporeal circulation during lung transplantation: a feasibility study //Journal of cardiothoracic and vascular anesthesia. – 2017. – Т. 31. – №. 3. – С. 931-938. |
| 163 | Shah P. R. et al. Extracorporeal support during bilateral sequential lung transplantation in patients with pulmonary hypertension: Risk Factors and Outcomes //Journal of Cardiothoracic and Vascular Anesthesia. – 2017. – Т. 31. – №. 2. – С. 418-425. |
| 164 | Bermudez C. A. et al. Extracorporeal membrane oxygenation as a bridge to lung transplant: midterm outcomes //The Annals of thoracic surgery. – 2011. – Т. 92. – №. 4. – С. 1226-1232. |
| 165 | Biscotti M., Sonett J., Bacchetta M. ECMO as bridge to lung transplant //Thoracic Surgery Clinics. – 2015. – Т. 25. – №. 1. – С. 17-25. |
| 166 | Todd E. M. et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation: a single-center experience in the present era //The Journal of thoracic and cardiovascular surgery. – 2017. – Т. 154. – №. 5. – С. 1798-1809. |
| 167 | Bartz R. R. et al. Pre-transplant mechanical ventilation and outcome in patients with cystic fibrosis //The Journal of heart and lung transplantation. – 2003. – Т. 22. – №. 4. – С. 433- 438. |
| 168 | Hamilton B. C. et al. Improved Survival After Lung Transplantation for Adults Requiring Pre-Operative Invasive Mechanical Ventilation: A National Cohort Study //The Journal of Heart and Lung Transplantation. – 2017. – Т. 36. – №. 4. – С. S94-S95. |
| 169 | Vermeijden J. W. et al. Lung transplantation for ventilator-dependent respiratory failure //The Journal of heart and lung transplantation. – 2009. – Т. 28. – №. 4. – С. 347-351. |
| | Benazzo A. et al. Twenty-year experience with extracorporeal life support as bridge to lung transplantation //The Journal of thoracic and cardiovascular surgery. – 2019. – Т. 157. – №. 6. – С. 2515-2525. e10. |
| | García-Gigorro R. et al. Mechanical support with venoarterial extracorporeal membrane oxygenation (ECMO-VA): Short-term and long-term prognosis after a successful weaning //Medicina Intensiva (English Edition). – 2017. – Т. 41. – №. 9. – С. 513-522. |
| 172 | Clajus C. et al. Therapeutic approach to respiratory infections in lung transplantation //Pulmonary pharmacology & therapeutics. – 2015. – Т. 32. – С. 149-154. |
| 173 | Nishi S. P. E., Valentine V. G., Duncan S. Emerging bacterial, fungal, and viral respiratory infections in transplantation //Infectious Disease Clinics. – 2010. – Т. 24. – №. 3. – С. 541- 555. |
| 174 | Vazquez R. et al. Invasive mold infections in lung and heart‐lung transplant recipients: Stanford University experience //Transplant Infectious Disease. – 2015. – Т. 17. – №. 2. – С. 259-266. |
| 175 | Geltner C., Lass-Flörl C. Invasive pulmonary Aspergillosis in organ transplants–Focus on lung transplants //Respiratory Investigation. – 2016. – Т. 54. – №. 2. – С. 76-84. |
| 176 | Kennedy C. C., Razonable R. R. Fungal infections after lung transplantation //Clinics in chest medicine. – 2017. – Т. 38. – №. 3. – С. 511-520. |
| 177 | Clark N. M. et al. Fungal infections complicating lung transplantation //Seminars in respiratory and critical care medicine. – Thieme Medical Publishers, 2018. – Т. 39. – №. 02. – С. 227-254. |
| 178 | Stamenkovic S. A. et al. Recurrence of hepatitis B after single lung transplantation //The Journal of heart and lung transplantation. – 1999. – Т. 18. – №. 12. – С. 1246-1250. |
| 179 | Hosenpud J. D. et al. Outcomes in patients who are hepatitis B surface antigen–positive before transplantation: an analysis and study using the joint ISHLT/UNOS thoracic registry //The Journal of heart and lung transplantation. – 2000. – Т. 19. – №. 8. – С. 781- 785. |
| 180 | Large S. R. Impact of hepatitis B core antibody positive donors in lung and heart-lung transplantation: an analysis of the UNOS database //Transplantation. – 2009. – Т. 88. – №. 6. – С. 759. |
| 181 | Galar A. et al. Serologic response to hepatitis B vaccination among lung transplantation candidates //Transplantation. – 2014. – Т. 98. – №. 6. – С. 676-679. |
| 182 | Doucette K. E. et al. Outcomes of lung transplantation in recipients with hepatitis C virus infection //American Journal of Transplantation. – 2016. – Т. 16. – №. 8. – С. 2445-2452. |
| | Koenig A. et al. Long‐term outcomes of lung transplant recipients with hepatitis C infection: a retrospective study of the US transplant registry //Alimentary pharmacology & therapeutics. – 2016. – Т. 44. – №. 3. – С. 271-278. |
| 184 | Bertani A. et al. Successful lung transplantation in an HIV‐and HBV‐positive patient with cystic fibrosis //American Journal of Transplantation. – 2009. – Т. 9. – №. 9. – С. 2190- 2196. |
| 185 | George M. P. Time to reconsider transplant criteria for candidacy? Lung transplantation feasibility in HIV-infected patients. – 2014. |
| 186 | Kern R. M. et al. The feasibility of lung transplantation in HIV-seropositive patients //Annals of the American Thoracic Society. – 2014. – Т. 11. – №. 6. – С. 882-889. |
| | Blumberg E. A., Rogers C. C., American Society of Transplantation Infectious Diseases Community of Practice. Solid organ transplantation in the HIV‐infected patient: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice //Clinical transplantation. – 2019. – Т. 33. – №. 9. – С. e13499. |
| 188 | ARIS R. M. et al. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex: survival linked to genomovar type //American journal of respiratory and critical care medicine. – 2001. – Т. 164. – №. 11. – С. 2102-2106. |
| 189 | De Soyza A. et al. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience //The Journal of Heart and Lung Transplantation. – 2010. – Т. 29. – №. 12. – С. 1395-1404. |
| 190 | Wang R. et al. Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia dolosa (genomovar VI) //Clinical Transplantation. – 2018. – Т. 32. – №. 5. – С. e13236. |
| 191 | Bills H. et al. Mycobacterium abscessus and lung transplantation: an international survey //The Journal of Heart and Lung Transplantation. – 2015. – Т. 34. – №. 4. – С. S304. |
| 192 | Bradbury R. A. et al. Prior diabetes mellitus is associated with increased morbidity in cystic fibrosis patients undergoing bilateral lung transplantation: an ‘orphan’area? A retrospective case–control study //Internal medicine journal. – 2009. – Т. 39. – №. 6. – С. 384-388. |
| 193 | Hackman K. L. et al. Diabetes is a major risk factor for mortality after lung transplantation //American Journal of Transplantation. – 2014. – Т. 14. – №. 2. – С. 438-445. |
| 194 | Živković S. A. et al. Neurologic complications following lung transplantation //Journal of the neurological sciences. – 2009. – Т. 280. – №. 1-2. – С. 90-93. |
| 195 | Mateen F. J. et al. Neurological complications following adult lung transplantation //American Journal of Transplantation. – 2010. – Т. 10. – №. 4. – С. 908-914. |
| 196 | Gamez J. et al. Influence of early neurological complications on clinical outcome following lung transplant //PloS one. – 2017. – Т. 12. – №. 3. – С. e0174092. |
| 197 | Goldstein L. S. et al. Central nervous system complications after lung transplantation //The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation. – 1998. – Т. 17. – №. 2. – С. 185-191. |
| 198 | Lipson D. A. et al. Giant gastric ulcers and risk factors for gastroduodenal mucosal disease in orthotopic lung transplant patients //Digestive diseases and sciences. – 1998. – Т. 43. – №. 6. – С. 1177-1185. |
| 199 | Hadjiliadis D. et al. Gastroesophageal reflux disease in lung transplant recipients //Clinical transplantation. – 2003. – Т. 17. – №. 4. – С. 363-368. |
| 200 | Sweet M. P. et al. Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation //The Journal of Thoracic and Cardiovascular Surgery. – 2007. – Т. 133. – №. 4. – С. 1078-1084. |
| 201 | Blondeau K. et al. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection //European Respiratory Journal. – 2008. – Т. 31. – №. 4. – С. 707-713. |
| 203 | Rudasill S. E. et al. Understanding lung transplant listing practices: Survival in lung transplant candidates who improve clinically to delisting //Surgery. – 2019. – Т. 166. – №. 6. – С. 1142-1147. |
| 204 | Keeshan B. C. et al. Lung transplant waitlist mortality: height as a predictor of poor outcomes //Pediatric Transplantation. – 2015. – Т. 19. – №. 3. – С. 294-300. |
| 205 | Smits J. M. et al. Evaluation of the lung allocation score in highly urgent and urgent lung transplant candidates in Eurotransplant //The Journal of heart and lung transplantation. – 2011. – Т. 30. – №. 1. – С. 22-28. |
| 206 | Colman R. et al. Outcomes of lung transplant candidates referred for co-management by palliative care: a retrospective case series //Palliative medicine. – 2015. – Т. 29. – №. 5. – С. 429-435. |
| 207 | Smith C. M. Patient selection, evaluation, and preoperative management for lung transplant candidates //Clinics in chest medicine. – 1997. – Т. 18. – №. 2. – С. 183-197. |
| 208 | De Meester J. et al. Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration //The Journal of heart and lung transplantation. – |
| | 1999. – Т. 18. – №. 6. – С. 563-571. |
| 209 | Maurer J. R. Indications, selection and pretransplant management of the potential recipient //The Transplantation and Replacement of Thoracic Organs. – Springer, Dordrecht, 1996. – С. 433-441. |
| 210 | Guggenheimer J., Eghtesad B., Stock D. J. Dental management of the (solid) organ transplant patient //Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. – 2003. – Т. 95. – №. 4. – С. 383-389. |
| 211 | Walterspacher S. et al. Dental care before lung transplantation: are we being too rigorous? //The clinical respiratory journal. – 2013. – Т. 7. – №. 2. – С. 220-225. |
| 212 | Marcinkowski A. et al. Deficits in oral health behavior and oral health status in patients after lung transplantation //The Clinical Respiratory Journal. – 2018. – Т. 12. – №. 2. – С. 721-730. |
| 213 | Schmalz G. et al. Oral health related quality of life depending on oral health and specific factors in patients after lung transplantation //The clinical respiratory journal. – 2018. – Т. 12. – №. 2. – С. 731-737. |
| 214 | Melkos A. B. et al. Organ transplantation-assessment of dental procedures //Oral Biosci Med. – 2005. – Т. 4. – С. 259-64. |
| 215 | Nosotti M. et al. Extracorporeal membrane oxygenation with spontaneous breathing as a bridge to lung transplantation //Interactive cardiovascular and thoracic surgery. – 2013. – Т. 16. – №. 1. – С. 55-59. |
| 216 | Lafarge M. et al. Experience of extracorporeal membrane oxygenation as a bridge to lung transplantation in France //The Journal of Heart and Lung Transplantation. – 2013. – Т. 32. – №. 9. – С. 905-913. |
| 217 | Hamilton B. C. S. et al. Improved survival after lung transplantation for adults requiring pre-operative invasive mechanical ventilation: A national cohort study //The Journal of Thoracic and Cardiovascular Surgery. – 2020. |
| 218 | Feldman D. et al. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary //The Journal of Heart and Lung Transplantation. – 2013. – Т. 32. – №. 2. – С. 157-187. |
| 219 | Bando K. et al. Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension //The Journal of thoracic and cardiovascular surgery. – 1994. – Т. 108. – №. 6. – С. 1056-1065. |
| 220 | Kendall S. W., Wallwork J. Heart-lung transplantation: indications and technique //Semin Thorac Cardiovasc Surg. – 1992. – Т. 4. – С. 101-106. |
| 221 | Idrees J. J., Pettersson G. B. State of the art of combined heart-lung transplantation for advanced cardiac and pulmonary dysfunction //Current cardiology reports. – 2016. – Т. 18. – №. 4. – С. 36. |
| 222 | Patterson G. A. INDICATIONS: Unilateral, Bilateral, Heart–Lung, and Lobar Transplant Procedures //Clinics in chest medicine. – 1997. – Т. 18. – №. 2. – С. 225-230. |
| 223 | Calhoon J. H. et al. Single lung transplantation: alternative indications and technique //The Journal of thoracic and cardiovascular surgery. – 1991. – Т. 101. – №. 5. – С. 816-825. |
| 224 | Waters P. F. Single lung transplant: Indications and technique //Semin Thorac Cardiovasc Surg. – 1992. – Т. 4. – С. 90-94. |
| 225 | Brouckaert J. et al. Double‐lung versus heart‐lung transplantation for precapillary pulmonary arterial hypertension: a 24‐year single‐center retrospective study //Transplant International. – 2019. – Т. 32. – №. 7. – С. 717-729. |
| 226 | Barlow C. W. et al. Heart-lung versus double-lung transplantation for suppurative lung disease //The Journal of thoracic and cardiovascular surgery. – 2000. – Т. 119. – №. 3. – С. 466-476. |
| 227 | Bonnette P. Logistic, technic and postoperative complications of lung and heart-lung transplantations //Revue de Pneumologie clinique. – 2010. – Т. 67. – №. 1. – С. 15-20. |
| 228 | Aigner C., Klepetko W. Bilateral lung transplantation //Operative Techniques in Thoracic and Cardiovascular Surgery. – 2012. – Т. 17. – №. 3. – С. 181-193. |
| 229 | Patterson G. A. et al. Comparison of outcomes of double and single lung transplantation for obstructive lung disease //The Journal of thoracic and cardiovascular surgery. – 1991. – Т. 101. – №. 4. – С. 623-632. |
| 230 | Low D. E. et al. Morbidity, mortality, and early results of single versus bilateral lung transplantation for emphysema //The Journal of thoracic and cardiovascular surgery. – 1992. – Т. 103. – №. 6. – С. 1119-1126. |
| 231 | Bains M. S. et al. The clamshell incision: an improved approach to bilateral pulmonary and mediastinal tumor //The Annals of thoracic surgery. – 1994. – Т. 58. – №. 1. – С. 30-33. |
| 232 | Luciani G. B., Starnes V. A. The clamshell approach for the surgical treatment of complex cardiopulmonary pathology in infants and children //European journal of cardio-thoracic surgery. – 1997. – Т. 11. – №. 2. – С. 298-306. |
| 233 | Macchiarini P. et al. Clamshell or sternotomy for double lung or heart-lung transplantation? //European journal of cardio-thoracic surgery. – 1999. – Т. 15. – №. 3. – С. 333-339. |
| 234 | Dark J. H. Median sternotomy for lung transplantation //Operative Techniques in Thoracic and Cardiovascular Surgery. – 2015. – Т. 20. – №. 1. – С. 87-103. |
| 235 | Cooper J. D. et al. Technique of successful lung transplantation in humans //The Journal of thoracic and cardiovascular surgery. – 1987. – Т. 93. – №. 2. – С. 173-181. |
| 236 | Hayanga J. W. A., D’Cunha J. The surgical technique of bilateral sequential lung transplantation //Journal of thoracic disease. – 2014. – Т. 6. – №. 8. – С. 1063. |
| 237 | Boasquevisque C. H. R. et al. Surgical techniques: lung transplant and lung volume reduction //Proceedings of the American Thoracic Society. – 2009. – Т. 6. – №. 1. – С. 66- 78. |
| 238 | Gust L. et al. Single-lung and double-lung transplantation: technique and tips //Journal of thoracic disease. – 2018. – Т. 10. – №. 4. – С. 2508. |
| 239 | Patterson G. A. Bilateral lung transplant: indications and technique //Semin Thorac Cardiovasc Surg. – 1992. – Т. 4. – №. 2. – С. 95-100. |
| 240 | Oto T. et al. Extracorporeal membrane oxygenation after lung transplantation: evolving technique improves outcomes //The Annals of thoracic surgery. – 2004. – Т. 78. – №. 4. – С. 1230-1235. |
| 241 | Aigner C. et al. Institutional experience with extracorporeal membrane oxygenation in lung transplantation //European journal of cardio-thoracic surgery. – 2007. – Т. 31. – №. 3. – С. 468-474. |
| 242 | Ius F. et al. Five-year experience with intraoperative extracorporeal membrane oxygenation in lung transplantation: Indications and midterm results //The Journal of Heart and Lung Transplantation. – 2016. – Т. 35. – №. 1. – С. 49-58. |
| 243 | Mulvihill M. S. et al. Extracorporeal membrane oxygenation following lung transplantation: indications and survival //The Journal of Heart and Lung Transplantation. – 2018. – Т. 37. – №. 2. – С. 259-267. |
| 244 | Hoechter D. J. et al. Extracorporeal circulation during lung transplantation procedures: a meta-analysis //Asaio Journal. – 2017. – Т. 63. – №. 5. – С. 551-561. |
| 245 | Ius F. et al. Lung transplantation on cardiopulmonary support: venoarterial extracorporeal membrane oxygenation outperformed cardiopulmonary bypass //The Journal of thoracic and cardiovascular surgery. – 2012. – Т. 144. – №. 6. – С. 1510-1516. |
| 246 | Pereszlenyi A. et al. Bilateral lung transplantation with intra-and postoperatively prolonged ECMO support in patients with pulmonary hypertension //European journal of cardio- thoracic surgery. – 2002. – Т. 21. – №. 5. – С. 858-863. |
| 247 | Machuca T. N. et al. Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation //The Journal of thoracic and cardiovascular surgery. – 2015. – Т. 149. – №. 4. – С. 1152-1157. |
| 248 | Biscotti M. et al. Comparison of extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation //The Journal of Thoracic and Cardiovascular Surgery. – 2014. – Т. 148. – №. 5. – С. 2410-2416. |
| 249 | Bermudez C. A. et al. Outcomes of intraoperative venoarterial extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation //The Annals of thoracic surgery. – 2014. – Т. 98. – №. 6. – С. 1936-1943. |
| 250 | Lick S. D. et al. Technique of controlled reperfusion of the transplanted lung in humans //The Annals of thoracic surgery. – 2000. – Т. 69. – №. 3. – С. 910-912. |
| 251 | Halldorsson A. et al. Controlled reperfusion after lung ischemia: implications for improved function after lung transplantation //The Journal of thoracic and cardiovascular surgery. – 1998. – Т. 115. – №. 2. – С. 415-425. |
| 252 | Ahmad S., Shlobin O. A., Nathan S. D. Pulmonary complications of lung transplantation //Chest. – 2011. – Т. 139. – №. 2. – С. 402-411. |
| 253 | Mulligan M. J. et al. The use of extended criteria donors decreases one-year survival in high-risk lung recipients: A review of the United Network of Organ Sharing Database //The Journal of thoracic and cardiovascular surgery. – 2016. – Т. 152. – №. 3. – С. 891- 898. e2. |
| 254 | Chaney J. et al. Lung donor selection criteria //Journal of thoracic disease. – 2014. – Т. 6. – №. 8. – С. 1032. |
| 255 | Snell G. I., Paraskeva M., Westall G. P. Donor selection and management //Seminars in respiratory and critical care medicine. – Thieme Medical Publishers, 2013. – Т. 34. – №. 03. – С. 361-370. |
| 256 | Van Raemdonck D. et al. Lung donor selection and management //Proceedings of the American Thoracic Society. – 2009. – Т. 6. – №. 1. – С. 28-38. |
| 257 | Rydberg L. ABO‐incompatibility in solid organ transplantation //Transfusion Medicine. – 2001. – Т. 11. – №. 4. – С. 325-342. |
| 258 | Strüber M. et al. Intentional ABO‐incompatible lung transplantation //American Journal of Transplantation. – 2008. – Т. 8. – №. 11. – С. 2476-2478. |
| 259 | Banner N. R. et al. Management of an ABO‐incompatible lung transplant //American Journal of Transplantation. – 2004. – Т. 4. – №. 7. – С. 1192-1196. |
| 260 | Grasemann H. et al. ABO‐incompatible lung transplantation in an infant //American Journal of Transplantation. – 2012. – Т. 12. – №. 3. – С. 779-781. |
| 261 | Gimferrer I., Nelson K. A. Immunology in Lung Transplantation //Lung Transplantation. – Springer, Cham, 2018. – С. 139-160. |
| 262 | Patel M. et al. Medium‐term outcome of an ABO incompatible lung transplant //American Journal of Transplantation. – 2010. – Т. 10. – №. 3. – С. 702-703. |
| 263 | Whited W. M. et al. Does donor age and double versus single lung transplant affect survival of young recipients? //The Annals of thoracic surgery. – 2018. – Т. 105. – №. 1. – С. 235-241. |
| 264 | Sommer W. et al. Survival and spirometry outcomes after lung transplantation from donors aged 70 years and older //The Journal of Heart and Lung Transplantation. – 2015. – Т. 34. – №. 10. – С. 1325-1333. |
| 265 | Hayes Jr D. et al. Influence of donor and recipient age in lung transplantation //The Journal of Heart and Lung Transplantation. – 2015. – Т. 34. – №. 1. – С. 43-49. |
| 266 | Bittle G. J. et al. The use of lung donors older than 55 years: a review of the United Network of Organ Sharing database //The Journal of Heart and Lung Transplantation. – 2013. – Т. 32. – №. 8. – С. 760-768. |
| 267 | Baldwin M. R. et al. Donor age and early graft failure after lung transplantation: a cohort study //American Journal of Transplantation. – 2013. – Т. 13. – №. 10. – С. 2685-2695. |
| 268 | Rech T. H. et al. Management of the brain-dead organ donor: a systematic review and meta-analysis //Transplantation. – 2013. – Т. 95. – №. 7. – С. 966-974. |
| 269 | McElhinney D. B. et al. Thoracic organ donor characteristics associated with successful lung procurement //Clinical transplantation. – 2001. – Т. 15. – №. 1. – С. 68-71. |
| 270 | Rech, Tatiana H., et al. "Management of the brain-dead organ donor: a systematic review and meta-analysis //Transplantation 95.7 (2013): 966-974. |
| 271 | Sutherasan Y., Vargas M., Pelosi P. Protective mechanical ventilation in the non-injured lung: review and meta-analysis //Critical care. – 2014. – Т. 18. – №. 2. – С. 211. |
| 272 | Yang D. et al. A meta-analysis of intraoperative ventilation strategies to prevent pulmonary complications //Annals of surgery. – 2016. – Т. 263. – №. 5. – С. 881-887. |
| 273 | Krutsinger D. et al. Lung transplantation from donation after cardiocirculatory death: a systematic review and meta-analysis //The Journal of Heart and Lung Transplantation. – 2015. – Т. 34. – №. 5. – С. 675-684. |
| 274 | Van Raemdonck D. E. et al. 5-year results from the ISHLT DCD lung transplant registry confirm excellent recipient survival from donation after circulatory death donors //The Journal of Heart and Lung Transplantation. – 2019. – Т. 38. – №. 4. – С. S103. |
| 275 | Bittle G. J. et al. Donor-Recipient Size Mismatch in Lung Transplantation Does Not Negatively Impact Survival: An Review of the UNOS Database //The Journal of Heart and Lung Transplantation. – 2013. – Т. 32. – №. 4. – С. S122-S123. |
| 276 | Mason D. P. et al. Matching donor to recipient in lung transplantation: how much does size matter? //The Journal of thoracic and cardiovascular surgery. – 2009. – Т. 137. – №. 5. – С. 1234-1240. e1. |
| 277 | Eberlein M. et al. Lung size mismatch in bilateral lung transplantation is associated with allograft function and bronchiolitis obliterans syndrome //Chest. – 2012. – Т. 141. – №. 2. – С. 451-460. |
| 278 | Eberlein M. et al. Lung size mismatch and primary graft dysfunction after bilateral lung transplantation //The Journal of Heart and Lung Transplantation. – 2015. – Т. 34. – №. 2. – С. 233-240. |
| 279 | Barnard J. B. et al. Size matching in lung transplantation: an evidence-based review //The Journal of Heart and Lung Transplantation. – 2013. – Т. 32. – №. 9. – С. 849-860. |
| 280 | Shigemura N. et al. Donor smoking history and age in lung transplantation: a revisit //Transplantation. – 2013. – Т. 95. – №. 3. – С. 513-518. |
| 281 | Bonser R. S. et al. Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry //The Lancet. – 2012. – Т. 380. – №. 9843. – С. 747-755. |
| 282 | Oto T. et al. A donor history of smoking affects early but not late outcome in lung transplantation //Transplantation. – 2004. – Т. 78. – №. 4. – С. 599-606. |
| 283 | Berman M. et al. Comparison of outcomes from smoking and nonsmoking donors: thirteen-year experience //The Annals of thoracic surgery. – 2010. – Т. 90. – №. 6. – С. 1786-1792. |
| 284 | Sabashnikov A. et al. Influence of donor smoking on midterm outcomes after lung transplantation //The Annals of thoracic surgery. – 2014. – Т. 97. – №. 3. – С. 1015-1021. |
| 285 | Taghavi S. et al. Double-lung transplantation can be safely performed using donors with heavy smoking history //The Annals of thoracic surgery. – 2013. – Т. 95. – №. 6. – С. 1912-1918. |
| 286 | Latchana N. et al. Preservation solutions for cardiac and pulmonary donor grafts: a review of the current literature //Journal of thoracic disease. – 2014. – Т. 6. – №. 8. – С. 1143. |
| 287 | Fischer S. et al. Low-potassium dextran preservation solution improves lung function after human lung transplantation //The Journal of thoracic and cardiovascular surgery. – 2001. – Т. 121. – №. 3. – С. 594-596. |
| 288 | Alvarez A. et al. Preservation with a retrograde second flushing of Eurocollins in clinical lung transplantation //Transplantation proceedings. – Elsevier, 1999. – Т. 31. – №. 1-2. – С. 1088-1090. |
| 289 | Chen C. Z. et al. Retrograde versus antegrade flush in canine left lung preservation for six hours //The Journal of heart and lung transplantation: the official publication of the |
| | International Society for Heart Transplantation. – 1996. – Т. 15. – №. 4. – С. 395-403. |
| 290 | Roberts R. F. et al. A comparison of the new preservation solution celsior to euro-collins and university of wisconsin solutions in lung reperfusion injury //Transplantation. – 1999. – Т. 67. – №. 1. – С. 152-155. |
| 291 | Mohara J. et al. A comparative study of Celsior and University of Wisconsin solutions based on 12-hr preservation followed by transplantation in canine models //The Journal of heart and lung transplantation. – 1999. – Т. 18. – №. 12. – С. 1202-1210. |
| 292 | Gohrbandt B. et al. Lung preservation with Perfadex or Celsior in clinical transplantation: a retrospective single-center analysis of outcomes //Transplantation. – 2015. – Т. 99. – №. 9. – С. 1933-1939. |
| 293 | Angel L. F. et al. Impact of a lung transplantation donor–management protocol on lung donation and recipient outcomes //American journal of respiratory and critical care medicine. – 2006. – Т. 174. – №. 6. – С. 710-716. |
| 294 | Miñambres E. et al. Effect of an intensive lung donor-management protocol on lung transplantation outcomes //The Journal of Heart and Lung Transplantation. – 2014. – Т. 33. – №. 2. – С. 178-184. |
| 295 | Mascia L. et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial //Jama. – 2010. – Т. 304. – №. 23. – С. 2620-2627. |
| 296 | Ulicny Jr K. S. et al. Cadaver lung donors: effect of preharvest ventilation on graft function //The Annals of thoracic surgery. – 1993. – Т. 55. – №. 5. – С. 1185-1191. |
| 297 | Van Raemdonck D. Thoracic organs: current preservation technology and future prospects; part 1: lung //Current opinion in organ transplantation. – 2010. – Т. 15. – №. 2. – С. 150- 155. |
| 298 | Hanna K. et al. Airway pressure release ventilation and successful lung donation //Archives of Surgery. – 2011. – Т. 146. – №. 3. – С. 325-328. |
| 299 | Albert S. et al. Comparison of “open lung” modes with low tidal volumes in a porcine lung injury model //Journal of Surgical Research. – 2011. – Т. 166. – №. 1. – С. e71-e81. |
| 300 | Noiseux N. et al. Pulmonary recruitment protocol for organ donors: a new strategy to improve the rate of lung utilization //Transplantation proceedings. – Elsevier, 2009. – Т. 41. – №. 8. – С. 3284-3289. |
| 301 | Chen C. Z. et al. Retrograde flush and cold storage for twenty-two to twenty-five hours lung preservation with and without prostaglandin E1 //The Journal of heart and lung transplantation: the official publication of the International Society for Heart |
| | Transplantation. – 1997. – Т. 16. – №. 6. – С. 658-666. |
| 302 | Wittwer T. et al. Retrograde flush perfusion with low-potassium solutions for improvement of experimental pulmonary preservation //The Journal of heart and lung transplantation. – 2000. – Т. 19. – №. 10. – С. 976-983. |
| 303 | Wittwer T. et al. Impact of retrograde graft preservation in Perfadex-based experimental lung transplantation //Journal of Surgical Research. – 2004. – Т. 117. – №. 2. – С. 239- 248. |
| 304 | Venuta F. et al. Preimplantation retrograde pneumoplegia in clinical lung transplantation //The Journal of Thoracic and Cardiovascular Surgery. – 1999. – Т. 118. – №. 1. – С. 107- 114. |
| 305 | Lund L. H. et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult heart transplantation report—2017; focus theme: allograft ischemic time //The Journal of Heart and Lung Transplantation. – 2017. – Т. 36. – №. 10. – С. 1037-1046. |
| 306 | Potestio C., Jordan D., Kachulis B. Acute postoperative management after lung transplantation //Best Practice & Research Clinical Anaesthesiology. – 2017. – Т. 31. – №. 2. – С. 273-284. |
| 307 | Lau C. L., Patterson G. A., Palmer S. M. Critical care aspects of lung transplantation //Journal of intensive care medicine. – 2004. – Т. 19. – №. 2. – С. 83-104. |
| 308 | Carlin B. W., Lega M., Veynovich B. Management of the patient undergoing lung transplantation: an intensive care perspective //Critical care nursing quarterly. – 2009. – Т. 32. – №. 1. – С. 49-57. |
| 309 | Kim S. Y. et al. Critical Care after Lung Transplantation //Acute and critical care. – 2018. – Т. 33. – №. 4. – С. 206. |
| 310 | Bonvillain R. W. et al. Post-operative infections in cystic fibrosis and non–cystic fibrosis patients after lung transplantation //The Journal of heart and lung transplantation. – 2007. – Т. 26. – №. 9. – С. 890-897. |
| 311 | Corris P. A. et al. Targeted Antibiotic Prophylaxis for Lung Transplantation in Cystic Fibrosis Patients Colonised with Pseudomonas a eruginosa Using Multiple Combination Bactericidal Testing //Journal of Transplantation. – 2012. |
| 312 | Aguilar‐Guisado M. et al. Pneumonia after lung transplantation in the RESITRA Cohort: a multicenter prospective study //American journal of transplantation. – 2007. – Т. 7. – №. 8. – С. 1989-1996. |
| 313 | Quon B. S., Goss C. H., Ramsey B. W. Inhaled antibiotics for lower airway infections //Annals of the American Thoracic Society. – 2014. – Т. 11. – №. 3. – С. 425-434. |
| 314 | Hayes Jr D. et al. Aerosolized vancomycin for the treatment of MRSA after lung transplantation //Respirology. – 2010. – Т. 15. – №. 1. – С. 184-186. |
| 315 | Ludwig C. et al. Inhalation with Tobramycin® to improve healing of tracheobronchial reconstruction //European journal of cardio-thoracic surgery. – 2009. – Т. 35. – №. 5. – С. 797-800. |
| 316 | Suhling H. et al. Inhaled colistin following lung transplantation in colonised cystic fibrosis patients //European Respiratory Journal. – 2013. – Т. 42. – №. 2. – С. 542-544. |
| 317 | Moore C. A. et al. Effect of aerosolized antipseudomonals on P seudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation //Transplant Infectious Disease. – 2017. – Т. 19. – №. 3. – С. e12688. |
| 318 | Carillo C. et al. Colistin-based treatment of multidrug-resistant gram-negative bacterial pulmonary infections after lung transplantation //Transplantation proceedings. – Elsevier, 2019. – Т. 51. – №. 1. – С. 202-205. |
| 319 | Patel T. S. et al. Antifungal prophylaxis in lung transplant recipients //Transplantation. – 2016. – Т. 100. – №. 9. – С. 1815-1826. |
| 320 | Calvo V. et al. Antifungal prophylaxis during the early postoperative period of lung transplantation //Chest. – 1999. – Т. 115. – №. 5. – С. 1301-1304. |
| 321 | Monforte V. et al. Nebulized amphotericin B concentration and distribution in the respiratory tract of lungtransplanted patients //Transplantation. – 2003. – Т. 75. – №. 9. – С. 1571-1574. |
| 322 | Koo S. et al. A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis //Transplantation. – 2012. – Т. 94. – №. 3. – С. 281-286. |
| 323 | Kruger R. M. et al. The impact of ganciclovir-resistant cytomegalovirus infection after lung transplantation //Transplantation. – 1999. – Т. 68. – №. 9. – С. 1272-1279. |
| 324 | Zamora M. R. et al. Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation //American Journal of Transplantation. – 2004. – Т. 4. – №. 10. – С. 1635-1642. |
| 325 | Kroshus T. J. et al. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation //The Journal of thoracic and cardiovascular surgery. – 1997. – Т. 114. – №. 2. – С. 195-202. |
| 326 | Ruttmann E. et al. Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation //Transplantation. – 2006. – Т. 81. – №. 10. – С. 1415-1420. |
| 327 | Chmiel C. et al. Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation //Clinical infectious diseases. – 2008. – Т. 46. – №. 6. – С. 831-839. |
| 328 | Palmer S. M. et al. Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial //Annals of internal medicine. – 2010. – Т. 152. – №. 12. – С. 761-769. |
| 329 | Geube M. A. et al. Increased intraoperative fluid administration is associated with severe primary graft dysfunction after lung transplantation //Anesthesia and analgesia. – 2016. – Т. 122. – №. 4. – С. 1081. |
| 330 | Schultze B. S. Fluid Management in Lung Transplant Patients //Nursing Clinics. – 2017. – Т. 52. – №. 2. – С. 301-308. |
| 331 | Baldwin M. R. et al. Hypoalbuminemia and early mortality after lung transplantation: a cohort study //American Journal of Transplantation. – 2012. – Т. 12. – №. 5. – С. 1256- 1267. |
| 332 | Kundu S., Herman S. J., Winton T. L. Reperfusion edema after lung transplantation: radiographic manifestations //Radiology. – 1998. – Т. 206. – №. 1. – С. 75-80. |
| 333 | Currey J. et al. Implementation of a management guideline aimed at minimizing the severity of primary graft dysfunction after lung transplant //The Journal of thoracic and cardiovascular surgery. – 2010. – Т. 139. – №. 1. – С. 154-161. |
| 334 | Beer A. et al. Mechanical ventilation after lung transplantation. An international survey of practices and preferences //Annals of the American Thoracic Society. – 2014. – Т. 11. – №. 4. – С. 546-553. |
| 335 | Barnes L. et al. Mechanical ventilation for the lung transplant recipient //Current pulmonology reports. – 2015. – Т. 4. – №. 2. – С. 88-96. |
| 336 | Thakuria L. et al. Mechanical ventilation after lung transplantation //Journal of critical care. – 2016. – Т. 31. – №. 1. – С. 110-118. |
| 337 | Lucangelo U. et al. Protective ventilation for lung transplantation //Current Opinion in Anesthesiology. – 2012. – Т. 25. – №. 2. – С. 170-174. |
| 338 | Verbeek G. L., Myles P. S. Intraoperative protective ventilation strategies in lung transplantation //Transplantation Reviews. – 2013. – Т. 27. – №. 1. – С. 30-35. |
| 339 | Verbeek G. L. et al. Intra‐operative protective mechanical ventilation in lung transplantation: a randomised, controlled trial //Anaesthesia. – 2017. – Т. 72. – №. 8. – С. |
| | 993-1004. |
| 340 | Mitchell J. B. et al. Differential lung ventilation after single-lung transplantation for emphysema //Journal of cardiothoracic and vascular anesthesia. – 2002. – Т. 16. – №. 4. – С. 459-462. |
| 341 | Kroshus T. J., Bolman III R. M., Kshettry V. R. Unilateral volume reduction after single- lung transplantation for emphysema //The Annals of thoracic surgery. – 1996. – Т. 62. – №. 2. – С. 363-368. |
| 342 | Weill D. et al. Acute native lung hyperinflation is not associated with poor outcomes after single lung transplant for emphysema //The Journal of heart and lung transplantation. – 1999. – Т. 18. – №. 11. – С. 1080-1087. |
| 343 | Yonan N. A. et al. Single lung transplantation for emphysema: predictors for native lung hyperinflation //The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation. – 1998. – Т. 17. – №. 2. – С. 192-201. |
| 344 | Anderson M. B. et al. Volume reduction surgery in the native lung after single lung transplantation for emphysema //The Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation. – 1997. – Т. 16. – №. 7. – С. 752-757. |
| 345 | Mullen J. C. et al. A randomized, controlled trial of daclizumab vs anti-thymocyte globulin induction for lung transplantation //The Journal of heart and lung transplantation. – 2007. – Т. 26. – №. 5. – С. 504-510. |
| 346 | Burton C. M. et al. The incidence of acute cellular rejection after lung transplantation: a comparative study of anti-thymocyte globulin and daclizumab //The Journal of heart and lung transplantation. – 2006. – Т. 25. – №. 6. – С. 638-647. |
| 347 | Hachem R. R. et al. The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry //Clinical transplantation. – 2008. – Т. 22. – №. 5. – С. 603-608. |
| 348 | Palmer S. M. et al. Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study //Chest. – 1999. – Т. 116. – №. 1. – С. 127-133. |
| 349 | Mattei M. F. et al. Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy //The Journal of heart and lung transplantation. – 2007. – Т. 26. – №. 7. – С. 693-699. |
| 350 | Clinckart F. et al. Basiliximab as an alternative to antithymocyte globulin for early immunosuppression in lung transplantation //Transplantation proceedings. – Elsevier, |
| | 2009. – Т. 41. – №. 2. – С. 607-609. |
| 351 | Borro J. M. et al. Comparative study of basiliximab treatment in lung transplantation //Transplantation proceedings. – Elsevier, 2005. – Т. 37. – №. 9. – С. 3996-3998. |
| 352 | Ailawadi G. et al. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation //The Journal of Thoracic and Cardiovascular Surgery. – 2008. – Т. 135. – №. 3. – С. 594-602. |
| 353 | Bhorade S. M., Stern E. Immunosuppression for lung transplantation //Proceedings of the American Thoracic Society. – 2009. – Т. 6. – №. 1. – С. 47-53. |
| 354 | Hachem R. R. et al. A comparison of basiliximab and anti-thymocyte globluin as induction agents after lung transplantation //The Journal of heart and lung transplantation. – 2005. – Т. 24. – №. 9. – С. 1320-1326. |
| 355 | Ramirez C. B., Marino I. R. The role of basiliximab induction therapy in organ transplantation //Expert opinion on biological therapy. – 2007. – Т. 7. – №. 1. – С. 137- 148. |
| 356 | Brennan D. C., Schnitzler M. A. Long-term results of rabbit antithymocyte globulin and basiliximab induction //New England Journal of Medicine. – 2008. – Т. 359. – №. 16. – С. 1736-1738. |
| 357 | Scheffert J. L., Raza K. Immunosuppression in lung transplantation //Journal of thoracic disease. – 2014. – Т. 6. – №. 8. – С. 1039. |
| 358 | Brock M. V. et al. Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab //The Journal of heart and lung transplantation. – 2001. – Т. 20. – №. 12. – С. 1282-1290. |
| 359 | Gerbase M. W. et al. Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation //Transplantation proceedings. – Elsevier, 2001. – Т. 33. – №. 3. – С. 2146-2147. |
| 360 | Treede, Hendrik, et al. "Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols //The Journal of heart and lung transplantation 20.5 (2001): 511-517. |
| 361 | Bhorade S. M. et al. Comparison of three tacrolimus‐based immunosuppressive regimens in lung transplantation //American Journal of Transplantation. – 2003. – Т. 3. – №. 12. – С. 1570-1575. |
| 362 | Reichenspurner H. Overview of tacrolimus-based immunosuppression after heart or lung transplantation //The Journal of heart and lung transplantation. – 2005. – Т. 24. – №. 2. – |
| | С. 119-130. |
| 363 | Zuckermann A. et al. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial //The Journal of thoracic and cardiovascular surgery. – 2003. – Т. 125. – №. 4. – С. 891-900. |
| 364 | Knoop C., Haverich A., Fischer S. Immunosuppressive therapy after human lung transplantation //European Respiratory Journal. – 2004. – Т. 23. – №. 1. – С. 159-171. |
| 365 | Reichenspurner H. et al. Optimization of the immunosuppressive protocol after lung transplantation //Transplantation. – 1999. – Т. 68. – №. 1. – С. 67-71. |
| 366 | Bittner H. B. et al. Preoperative introduction and maintenance immunosuppression therapy of oral-only tacrolimus, mycophenolate mofetil and steroids reduce acute rejection episodes after lung transplantation //European journal of cardio-thoracic surgery. – 2010. – Т. 38. – №. 3. – С. 268-276. |
| 367 | Zuckermann A. et al. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial //The Journal of thoracic and cardiovascular surgery. – 2003. – Т. 125. – №. 4. – С. 891-900. |
| 368 | Hachem R. R. et al. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation //The Journal of heart and lung transplantation. – 2007. – Т. 26. – №. 10. – С. 1012-1018. |
| 369 | Keenan R. J. et al. Clinical trial of tacrolimus versus cyclosporine in lung transplantation //The Annals of thoracic surgery. – 1995. – Т. 60. – №. 3. – С. 580-585. |
| 370 | Treede H. et al. Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols //The Journal of heart and lung transplantation. – 2001. – Т. 20. – №. 5. – С. 511-517. |
| 371 | Artz M. A. et al. Conversion from cyclosporine to tacrolimus improves quality‐of‐life indices, renal graft function and cardiovascular risk profile //American Journal of Transplantation. – 2004. – Т. 4. – №. 6. – С. 937-945. |
| 372 | Thorp M. et al. The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol //Transplantation. – 2000. – Т. 69. – №. 6. – С. 1218-1221. |
| 373 | Emre S. et al. Treatment of tacrolimus‐related adverse effects by conversion to cyclosporine in liver transplant recipients //Transplant international. – 2000. – Т. 13. – №. 1. – С. 73-78. |
| 374 | Borro J. M. et al. Conversion from cyclosporine to tacrolimus stabilizes the course of lung function in lung transplant recipients with bronchiolitis obliterans syndrome //Transplantation proceedings. – Elsevier, 2007. – Т. 39. – №. 7. – С. 2416-2419. |
| 375 | Sarahrudi K. et al. The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after lung transplantation //Transplant international. – 2002. – Т. 15. – №. 1. – С. 24-28. |
| 376 | Treede H. et al. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation //The Journal of heart and lung transplantation. – 2012. – Т. 31. – №. 8. – С. 797-804. |
| 377 | Verleden G. M., Besse T., Maes B. Successfull conversion from cyclosporine to tacrolimus for gastric motor dysfunction in a lung transplant recipient //Transplantation. – 2002. – Т. 73. – №. 12. – С. 1974-1976. |
| 378 | Cairn J. et al. Time-related changes in pulmonary function after conversion to tacrolimus in bronchiolitis obliterans syndrome //The Journal of heart and lung transplantation. – 2003. – Т. 22. – №. 1. – С. 50-57. |
| 379 | Myers J. N. et al. Successful use of cyclosporine in a lung transplant recipient with tacrolimus-associated hemolytic uremic syndrome //The Journal of heart and lung transplantation. – 1999. – Т. 18. – №. 10. – С. 1024-1026. |
| 380 | James J. A. et al. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus //Journal of clinical periodontology. – 2000. – Т. 27. – №. 2. – С. 144-148. |
| 381 | Williams D., Haragsim L. Calcineurin nephrotoxicity //Advances in chronic kidney disease. – 2006. – Т. 13. – №. 1. – С. 47-55. |
| 382 | Olyaei A. J., de Mattos A. M., Bennett W. M. Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies //Current opinion in critical care. – 2001. – Т. 7. – №. 6. – С. 384-389. |
| 383 | Burdmann E. A. et al. Cyclosporine nephrotoxicity //Seminars in nephrology. – WB Saunders, 2003. – Т. 23. – №. 5. – С. 465-476. |
| 384 | Sikma M. A. et al. High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injury //European journal of clinical pharmacology. – 2017. – Т. 73. – №. 5. – С. 573-580. |
| 385 | Wehbe E. et al. Recovery from AKI and short-and long-term outcomes after lung transplantation //Clinical Journal of the American Society of Nephrology. – 2013. – Т. 8. – №. 1. – С. 19-25. |
| 386 | Bennett D. et al. Postoperative acute kidney injury in lung transplant recipients //Interactive cardiovascular and thoracic surgery. – 2019. – Т. 28. – №. 6. – С. 929-935. |
| 387 | Sikma M. A. et al. Pharmacokinetics and toxicity of tacrolimus early after heart and lung transplantation //American Journal of Transplantation. – 2015. – Т. 15. – №. 9. – С. 2301- 2313. |
| 388 | Shitrit D. et al. Use of sirolimus and low-dose calcineurin inhibitor in lung transplant recipients with renal impairment: results of a controlled pilot study //Kidney international. – 2005. – Т. 67. – №. 4. – С. 1471-1475. |
| 389 | Groetzner J. et al. Conversion to sirolimus and mycophenolate can attenuate the progression of bronchiolitis obliterans syndrome and improves renal function after lung transplantation //Transplantation. – 2006. – Т. 81. – №. 3. – С. 355-360. |
| 390 | Parada M. T., Alba A., Sepúlveda C. Everolimus in lung transplantation in Chile //Transplantation proceedings. – Elsevier, 2010. – Т. 42. – №. 1. – С. 328-330. |
| 391 | Stephany B. R. et al. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease //The Journal of heart and lung transplantation. – 2009. – Т. 28. – №. 6. – С. 564-571. |
| 392 | Roman A. et al. A retrospective 12-month study of conversion to everolimus in lung transplant recipients //Transplantation proceedings. – Elsevier, 2011. – Т. 43. – №. 7. – С. 2693-2698. |
| 393 | Schneer S. et al. Renal function preservation with the mTOR inhibitor, Everolimus, after lung transplant //Clinical transplantation. – 2014. – Т. 28. – №. 6. – С. 662-668. |
| 394 | Venuta F. et al. Recovery of chronic renal impairment with sirolimus after lung transplantation //The Annals of thoracic surgery. – 2004. – Т. 78. – №. 6. – С. 1940-1943. |
| 395 | Landin L. et al. Improvement in renal function after late conversion to sirolimus-based immunosuppression in composite tissue allotransplantation //Transplantation. – 2010. – Т. 90. – №. 6. – С. 691-692. |
| 396 | Gullestad L. et al. Long‐term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open‐label, randomized trial //Transplant International. – 2016. – Т. 29. – №. 7. – С. 819-829. |
| 397 | Gottlieb J. et al. A randomized trial of everolimus‐based quadruple therapy vs standard triple therapy early after lung transplantation //American Journal of Transplantation. – 2019. – Т. 19. – №. 6. – С. 1759-1769. |
| 398 | Palmer S. M. et al. Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection //Transplantation. – 2001. – Т. 71. – №. 12. – С. 1772-1776. |
| 399 | Whyte R. I. et al. Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation //The Annals of thoracic surgery. – 1997. – Т. 64. – №. 4. – С. 945-948. |
| 400 | Ross D. J. et al. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience //The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation. – 1998. – Т. 17. – №. 8. – С. 768-774. |
| 401 | Zuckermann A. et al. Comparison between mycophenolate mofetil-and azathioprine-based immunosuppressions in clinical lung transplantation //The Journal of heart and lung transplantation. – 1999. – Т. 18. – №. 5. – С. 432-440. |
| 402 | Celik M. R. et al. Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort study //The Journal of heart and lung transplantation. – 2009. – Т. 28. – №. 7. – С. 697-703. |
| 403 | Cummins D. et al. Myelosuppression associated with azathioprine-allopurinol interaction after heart and lung transplantation //Transplantation. – 1996. – Т. 61. – №. 11. – С. 1661- 1662. |
| 404 | Snell G. I. et al. Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double‐blind clinical trial //American journal of transplantation. – 2006. – Т. 6. – №. 1. – С. 169-177. |
| 405 | Ruttens D. et al. Prophylactic azithromycin therapy after lung transplantation: post hoc analysis of a randomized controlled trial //American Journal of Transplantation. – 2016. – Т. 16. – №. 1. – С. 254-261. |
| 406 | Corris P. A. et al. A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation //Thorax. – 2015. – Т. 70. – №. 5. – С. 442-450. |
| 407 | Vos R. et al. A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation //European Respiratory Journal. – 2011. – Т. 37. – №. 1. – С. 164-172. |
| 408 | Kingah P. L., Muma G., Soubani A. Azithromycin improves lung function in patients with post‐lung transplant bronchiolitis obliterans syndrome: a meta‐analysis //Clinical Transplantation. – 2014. – Т. 28. – №. 8. – С. 906-910. |
| 409 | Olivari M. T. et al. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation //Journal of Heart and Lung Transplantation. – 1995. – |
| | Т. 14. – №. 1 I. – С. 127-135. |
| 410 | Taylor D. O. et al. Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy //The Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation. – 1996. – Т. 15. – №. 10. – С. 1039-1046. |
| 411 | Borro J. M. et al. Steroid withdrawal in lung transplant recipients //Transplantation proceedings. – Elsevier, 2005. – Т. 37. – №. 9. – С. 3991-3993. |
| 412 | Shitrit D. et al. Successful steroid withdrawal in lung transplant recipients: result of a pilot study //Respiratory medicine. – 2005. – Т. 99. – №. 5. – С. 596-601. |
| 413 | De Pablo A. et al. Recommendations on the use of everolimus in lung transplantation //Transplantation Reviews. – 2013. – Т. 27. – №. 1. – С. 9-16. |
| 414 | Azzola A. et al. Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation1 //Transplantation. – 2004. – Т. 77. – №. 2. – С. 275-280. |
| 415 | McShane P. J., Garrity Jr E. R. Minimization of immunosuppression after lung transplantation: current trends //Transplant International. – 2009. – Т. 22. – №. 1. – С. 90- 95. |
| 416 | Strueber M. et al. Everolimus versus mycophenolate mofetil de novo after lung transplantation: a prospective, randomized, open‐label trial //American Journal of Transplantation. – 2016. – Т. 16. – №. 11. – С. 3171-3180. |
| 417 | Parada M. T. et al. Long-term use of everolimus in lung transplant patients //Transplantation proceedings. – Elsevier, 2011. – Т. 43. – №. 6. – С. 2313-2315. |
| 418 | Ivulich S. et al. The Successful Evolution of Everolimus Based Immunosuppression (IS) in a Large Lung Transplant (LTx) Cohort: 14 Years Experience //The Journal of Heart and Lung Transplantation. – 2020. – Т. 39. – №. 4. – С. S322. |
| 419 | Salman J. et al. Role for primary immunosuppression with everolimus after pulmonary transplantation //Transplant immunology. – 2018. – Т. 49. – С. 12-19. |
| 420 | Sciurba F. C. et al. Evidence of an altered pattern of breathing during exercise in recipients of heart–lung transplants //New England Journal of Medicine. – 1988. – Т. 319. – №. 18. – С. 1186-1192. |
| 421 | Jing G. Q. et al. Pulmonary rehabilitation after lung transplantation with severe complications: A case report //Canadian journal of respiratory therapy: CJRT= Revue canadienne de la therapie respiratoire: RCTR. – 2017. – Т. 53. – №. 3. – С. 45. |
| 422 | Munro P. E. et al. Pulmonary rehabilitation following lung transplantation |
| | //Transplantation proceedings. – Elsevier, 2009. – Т. 41. – №. 1. – С. 292-295. |
| 423 | Theodore J. et al. Cardiopulmonary function at maximum tolerable constant work rate exercise following human heart-lung transplantation //Chest. – 1987. – Т. 92. – №. 3. – С. 433-439. |
| 424 | Banner N. R. et al. Cardiopulmonary response to dynamic exercise after heart and combined heart-lung transplantation //Heart. – 1989. – Т. 61. – №. 3. – С. 215-223. |
| 425 | Maury G. et al. Skeletal muscle force and functional exercise tolerance before and after lung transplantation: a cohort study //American Journal of Transplantation. – 2008. – Т. 8. – №. 6. – С. 1275-1281. |
| 426 | Langer D. et al. Exercise training after lung transplantation improves participation in daily activity: a randomized controlled trial //American Journal of Transplantation. – 2012. – Т. 12. – №. 6. – С. 1584-1592. |
| 427 | Stiebellehner L. et al. Aerobic endurance training program improves exercise performance in lung transplant recipients //Chest. – 1998. – Т. 113. – №. 4. – С. 906-912. |
| 428 | Dierich M. et al. The influence of clinical course after lung transplantation on rehabilitation success //Transplant International. – 2013. – Т. 26. – №. 3. – С. 322-330. |
| 429 | Mathur S., Hornblower E., Levy R. D. Exercise training before and after lung transplantation //The Physician and sportsmedicine. – 2009. – Т. 37. – №. 3. – С. 78-87. |
| 430 | Walsh J. R. et al. Impaired exercise capacity after lung transplantation is related to delayed recovery of muscle strength //Clinical Transplantation. – 2013. – Т. 27. – №. 4. – С. E504- E511. |
| 431 | Wang X. N. et al. Skeletal muscle oxidative capacity, fiber type, and metabolites after lung transplantation //American journal of respiratory and critical care medicine. – 1999. – Т. 160. – №. 1. – С. 57-63. |
| 432 | Powrie D. J. The BODE index: a new grading system in COPD //Thorax. – 2004. – Т. 59. – №. 5. – С. 427-427. |
| 433 | Kerem E. et al. Prediction of mortality in patients with cystic fibrosis //New England Journal of Medicine. – 1992. – Т. 326. – №. 18. – С. 1187-1191. | Замечание №7 |
| 434 | Ramos K. J. et al. Heterogeneity in survival in adult patients with cystic fibrosis with FEV1< 30% of predicted in the United States //Chest. – 2017. – Т. 151. – №. 6. – С. 1320-1328. | |
| 435 | Hayes Jr D. et al. Mortality risk and pulmonary function in adults with cystic fibrosis at time of wait listing for lung transplantation //The Annals of Thoracic Surgery. – 2015. – Т. 100. – №. 2. – С. 474-479. | |
| 436 | Lehr C. J. et al. Effect of including important clinical variables on accuracy of the lung allocation score for cystic fibrosis and chronic obstructive pulmonary disease //American journal of respiratory and critical care medicine. – 2019. – Т. 200. – №. 8. – С. 1013-1021. | |
| 437 | Belkin R. A. et al. Risk factors for death of patients with cystic fibrosis awaiting lung transplantation //American journal of respiratory and critical care medicine. – 2006. – Т. 173. – №. 6. – С. 659-666. | |
| 438 | Solé A. et al. Patient-reported symptoms and functioning as indicators of mortality in advanced cystic fibrosis: A new tool for referral and selection for lung transplantation //The Journal of Heart and Lung Transplantation. – 2016. – Т. 35. – №. 6. – С. 789-794. | |
| 439 | Hayes Jr D. et al. Pulmonary hypertension in cystic fibrosis with advanced lung disease //American journal of respiratory and critical care medicine. – 2014. – Т. 190. – №. 8. – С. 898-905. | |
| 440 | Hayes Jr D. et al. Pulmonary artery pressure and benefit of lung transplantation in adult cystic fibrosis patients //The Annals of Thoracic Surgery. – 2016. – Т. 101. – №. 3. – С. 1104-1109. | |
| 441 | Lord R. W. et al. Pneumothorax in cystic fibrosis: beyond the guidelines //Paediatric Respiratory Reviews. – 2016. – Т. 20. – С. 30-33. | |
| 442 | de Boer K. et al. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis //Thorax. – 2011. – Т. 66. – №. 8. – С. 680-685. | |
| 443 | Nkam L. et al. A 3-year prognostic score for adults with cystic fibrosis //Journal of Cystic Fibrosis. – 2017. – Т. 16. – №. 6. – С. 702-708. | |
| 444 | Flight W. G. et al. Outcomes following bronchial artery embolisation for haemoptysis in cystic fibrosis //CardioVascular and Interventional Radiology. – 2017. – Т. 40. – №. 8. – С. 1164-1168. | |
| 445 | Flume P. A. et al. Massive hemoptysis in cystic fibrosis //Chest. – 2005. – Т. 128. – №. 2. – С. 729-738. | |
| 446 | Town J. A., Monroe E. J., Aitken M. L. Deaths related to bronchial arterial embolization in patients with cystic fibrosis: three cases and an institutional review //Chest. – 2016. – Т. 150. – №. 4. – С. e93-e98. | |
| 447 | Kerem E. et al. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry //European Respiratory Journal. – 2014. – Т. 43. – №. 1. – С. 125-133. | |
| 448 | Martin C. et al. Prognostic value of six minute walk test in cystic fibrosis adults //Respiratory medicine. – 2013. – Т. 107. – №. 12. – С. 1881-1887. | |
| 449 | Robinson W., Waltz D. A. FEV1 as a guide to lung transplant referral in young patients with cystic fibrosis //Pediatric pulmonology. – 2000. – Т. 30. – №. 3. – С. 198-202. | |
| 450 | Benden, Christian. "Specific aspects of children and adolescents undergoing lung transplantation." Current opinion in organ transplantation 17.5 (2012): 509-514. | Замечание 10 |
| 451 | Schmid, Florian A., and Christian Benden. "Special considerations for the use of lung transplantation in pediatrics." Expert Review of Respiratory Medicine 10.6 (2016): 655-662. | |
| 452 | Benden, Christian. "Pediatric lung transplantation." Journal of Thoracic Disease 9.8 (2017): 2675. | |
| 453 | Blondeau, Kathleen, et al. "Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection." European Respiratory Journal 31.4 (2008): 707-713. | Замечание 23 |
| 454 | D'ovidio, F., and S. Keshavjee. "Gastroesophageal reflux and lung transplantation." Diseases of the Esophagus 19.5 (2006): 315-320. | |
| 455 | Sweet, M. P., et al. "Gastro-oesophageal reflux and aspiration in patients with advanced lung disease." Thorax 64.2 (2009): 167-173. | |
| 456 | Button, Brenda M., et al. "Gastroesophageal reflux (symptomatic and silent): a potentially significant problem in patients with cystic fibrosis before and after lung transplantation." The Journal of heart and lung transplantation 24.10 (2005): 1522-1529. | |
| 457 | Sweet, Matthew P., et al. "Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation." The Journal of Thoracic and Cardiovascular Surgery 133.4 (2007): 1078-1084. | |
| 458 | Sáez‐ Giménez, Berta, et al. "Prophylaxis with enoxaparin for prevention of venous thromboembolism after lung transplantation: a retrospective study." Transplant International 30.12 (2017): 1266-1274. | |
| 459 | Fan, L., et al. "Incidence and influencing factors of venous thromboembolism after lung transplantation." Zhonghua yi xue za zhi 99.24 (2019): 1848-1852. | |
| 460 | Kanade, R., et al. "Characteristics and outcomes among patients with early venous thromboembolic events after lung transplant." Transplantation proceedings. Vol. 53. No. 1. Elsevier, 2021. | |
| 461 | Aboagye, Jonathan K., et al. "Venous thromboembolism in patients hospitalized for lung transplantation." The Annals of Thoracic Surgery 105.4 (2018): 1071-1076. | |
| 462 | Geube, Mariya A., et al. "Increased intraoperative fluid administration is associated with severe primary graft dysfunction after lung transplantation." Anesthesia and analgesia 122.4 (2016): 1081. | Замечание 24 |
| 463 | Myles, Paul S., Greg I. Snell, and Glen P. Westall. "Lung transplantation." Current Opinion in Anesthesiology 20.1 (2007): 21-26. | |
| 464 | Potestio, Christopher, Desmond Jordan, and Bessie Kachulis. "Acute postoperative management after lung transplantation." Best Practice & Research Clinical Anaesthesiology 31.2 (2017): 273-284. | |
| 465 | Burton, Christopher M., et al. "The incidence of acute cellular rejection after lung transplantation: a comparative study of anti-thymocyte globulin and daclizumab." The Journal of heart and lung transplantation 25.6 (2006): 638- 647. | Замечание 25 |
| 466 | Palmer, Scott M., et al. "Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study." Chest 116.1 (1999): 127-133. | |
| 467 | Hachem, Ramsey R., et al. "A comparison of basiliximab and anti-thymocyte globluin as induction agents after lung transplantation." The Journal of heart and lung transplantation 24.9 (2005): 1320-1326. | |
| 468 | Goldfarb, Samuel B., et al. "Induction therapy with antithymocyte globulin before reperfusion." The Annals of thoracic surgery 90.4 (2010): 1110-1115. | |
| 469 | Snell, G. I., et al. "A randomized, double‐ blind, placebo‐ controlled, multicenter study of rabbit ATG in the prophylaxis of acute rejection in lung transplantation." American Journal of Transplantation 14.5 (2014): 1191- 1198. | |
| 470 | Clinckart, F., et al. "Basiliximab as an alternative to antithymocyte globulin for early immunosuppression in lung transplantation." Transplantation proceedings. Vol. 41. No. 2. Elsevier, 2009. | Замечание 26 |
| 471 | Borro, J. M., et al. "Comparative study of basiliximab treatment in lung transplantation." Transplantation proceedings. Vol. 37. No. 9. Elsevier, 2005. | |
| 472 | de la Torre, M., et al. "Basiliximab in lung transplantation: preliminary experience." Transplantation proceedings. Vol. 37. No. 3. Elsevier, 2005. | |
| 473 | Parekh K., Trulock E., Patterson G. A. Use of cyclosporine in lung transplantation //Transplantation proceedings. – Elsevier, 2004. – Т. 36. – №. 2. – С. S318-S322. | Замечание 27 |
| 474 | Zuckermann A. et al. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial //The Journal of thoracic and cardiovascular surgery. – 2003. – Т. 125. – №. 4. – С. 891-900. | |
| 475 | Song J. H. et al. Feasibility of immediate in-Intensive Care Unit pulmonary rehabilitation after lung transplantation: A single center experience //Acute and Critical Care. – 2018. – Т. 33. – №. 3. – С. 146. | Замечание 34-35 |
| 476 | Choi E. J. et al. Intensive pulmonary rehabilitation in a pediatric lung transplantation patient: A case report //Medicine. – 2021. – Т. 100. – №. 17. | |